Drug recall · July 30, 2014
Invanz (ertapenem)1 gm/100 mL 0.9%NS recall
Why: Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Invanz (ertapenem)1 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29157, Discard After 05/19/14; Rx # 29097, Discard After 05/20/14
- Lots / codes
Rx # 29157, Exp 5/19/14; Rx # 29097, Exp 5/20/14
- Quantity
- 12 units
- Company
- Franck's Lab Inc dba Trinity Care Solutions, Ocala, FL
- Distribution
- Florida
- Initiated
- May 15, 2014 · Voluntary: Firm initiated
- Classified
- July 24, 2014
- Reported
- July 30, 2014
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ertapenem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.